RecruitingNCT05397392

Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

1,200 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients meet the diagnosis of various types of cardiorenal syndrome according to the classification standards of various types formulated by KDIGO and ADQI expert consensus. Different syndromes were identified and classified into five subtypes. Acute CRS (type 1): acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. Chronic cardio-renal syndrome (type 2): chronic abnormalities in heart function (CHF-CHD) leading to kidney injury and/or dysfunction. Acute reno-cardiac syndrome (type 3): acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction. Chronic reno-cardiac syndrome (type 4): chronic kidney disease leading to heart injury, disease, and/or dysfunction. Secondary CRS (type 5): systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.

Exclusion Criteria1

  • Pregnant or breastfeeding women; Female patients with recent birth plans; Patients who cannot follow up on medications.

Interventions

OTHERguideline recommended routine treatment

Locations(1)

Nanjing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05397392


Related Trials